SANUWAVE Amends Credit Agreement, Waives Coverage-Ratio Default for $5,000 Fee
SANUWAVE amended its credit agreement with JPMorgan Chase and lenders, waiving a coverage-ratio default for a $5,000 fee. The agreement tightened consent requirements for acquisitions and equity repurchases, and lowered two debt and investment limits from $500,000 to $250,000. The amendment was signed on October 28, 2026.
How this was made

The 30-second read
Why it matters
The amendment tightens financing terms but avoids an immediate default, likely resulting in modest stock pressure.
Market read
A small‑cap health‑tech firm disclosed a financing amendment that may slightly affect its share price.
What to watch
Potential upside if the waiver prevents a default that would have triggered a larger credit downgrade.
Background
SANUWAVE Health, Inc. filed an 8‑K reporting an amendment and waiver to its credit agreement with JPMorgan Chase and participating lenders.
Ticker impact
SANUWAVE amended its credit agreement, waiving a coverage‑ratio default for a $5,000 fee and tightening consent requirements.
likely modest downside as investors price in tighter financing terms
The $5,000 fee is trivial, but the reduced debt limits and stricter covenants signal tighter liquidity, which can pressure the stock.
Market effects
May prompt peers in the health‑tech financing space to review covenant structures.
Limited to U.S. small‑cap market; no broader regional effect.
Minimal global relevance.
Counterpoint
The amendment could be seen as a proactive step to avoid default, preserving credit standing.
Key entities
- companySANUWAVE Health, Inc.
Issuer of the credit agreement amendment.
- lenderJPMorgan Chase Bank
Primary lender granting the waiver.
